Background Image

AN ESTABLISHED & GROWING PORTFOLIO

Solutions that support patient needs

LEARN MORE

Therapy Area

  • Analgesia
    TradeGeneric Name
    OxyContin®, OxyContin NEO®Oxycodone
    OxyNorm®Oxycodone
    MST Continus®Morphine
    Targin®Oxycodone / Naloxone
    Sovenor®Buprenorphine
    Lignopad®Lidocaine
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.
  • Oncology
    TradeGeneric Name
    Folotyn®Pralatrexate
    Aloxi®Palonosetron
     Akynzeo®Netupitant / Palonosetron
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.
  • Ophthalmology
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.
  • Respiratory
    TradeGeneric Name
    Flutiform®Fluticasone Propionate / Formoterol Fumarate Dihydrate
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.
  • Specialty Care
    TradeGeneric Name
    Lodotra®Prednisone
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.
  • Consumer Healthcare
    TradeGeneric Name
    BETADINE®Povidone-iodine
    BETAPLAST®N/A
    BETADINE® Repigel®Povidone-iodine
    BETADINE® Feminine Wash Daily Use, BETADINE® Feminine Wash Foam Daily UseN/A
    BETADINE® Cold DefenceN/A
    There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.

Please refer to individual countries for full product indication, and local prescribing information.

Mundipharma actively works to ensure that its medicines are marketed responsibly and in accordance with the regulatory frameworks in each country it operates in. Mundipharma prides itself on being an ethical company, and continues to work closely with regulators, and within strict regulatory constraints, to address the unmet need of patients across the emerging world.

Regulatory requirements in various countries limit the product information that Mundipharma Pte Ltd can provide. Please refer to your local representative office and the locally approved prescribing information for more details on the product and indications. Furthermore, Mundipharma Pte Ltd provides the information for readers from many countries in the Asia Pacific, Middle East, Africa and Latin America region. Mundipharma Pte Ltd is providing the information as of this date and does not undertake any obligation to update any forward-looking statements contained in this website as a result of new information, future events or otherwise.

® : OxyContin, OxyNEO, OxyNorm, MST Continus, MS Contin, , Targin, , Sovenor, , Lignopad, , Flutiform, , Targin, Betadine, Betaplast, and Repithel are Registered Trademarks of Mundipharma in Singapore and are Registered Trademarks or Trademarks of Mundipharma in other countries. Folotyn – is a Registered Trademark of Allos Therapeutics, Inc;; Lodotra is a Registered Trademark of Horizon Pharma AG;

Medicines include medical devices.

®: ALOXI and AKYNZEO are Registered Trademarks in Singapore and Registered Trademarks or Trademarks in other countries, of Helsinn Healthcare SA, Switzerland used under license.

Analgesia

Over the past 60 years, Mundipharma has introduced a number of products that have transformed the way pain is treated, offering oral, transdermal and parenteral delivery of analgesia to suit patient needs.

 

The product range includes:

OxyContin® and OxyNEO® are prolonged-release tablets containing oxycodone.

OxyNorm®is an immediate-release formulation that contains the active ingredient

Lignopad® plaster contains 5% lidocaine in a medicated plaster formulation.

MST Continus® is a prolonged release tablet that contains morphine sulfate.

Targin® is a prolonged release tablet that contains a combination of the opioid agonist oxycodone and the opioid antagonist naloxone.

There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.

Background Image

Oncology

The existing range of oncology products includes treatments for neuro-oncological and haematological malignancies.

The product range includes:

AKYNZEO® is a capsule that contains a combination of Netupitant/Palonosetron.

ALOXI® is a solution for injection that contains Palonosetron.

Folotyn® is a solution for injection that contains Pralatrexate.

There are medicines in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore.

Background Image

Opthalmology

There are medicines in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore.

Background Image

Respiratory

Mundipharma is committed to building a presence in respiratory disease, particularly asthma, which is a chronic and debilitating disease that affects approximately 300 million people worldwide.

 

The product range includes:

Flutiform® (fluticasone/formoterol) – a combination therapy in an aerosol delivery system (pressurized metered dose inhaler or pMDI) that brings together fluticasone propionate, an inhaled corticosteroid, with formoterol fumarate, a long-acting β2 agonist.

There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.

 

Background Image

Specialty Care

Rheumatoid arthritis (RA) is a chronic and progressive auto-immune disease that causes swelling and damage to cartilage and bone around the joints, most commonly hands, feet and wrists. A common and debilitating symptom of RA is morning stiffness of the affected joints. RA is a painful condition and can have a negative impact on a person’s ability to perform tasks on a day-to-day basis.*

 

The product range includes:

LODOTRA® is a modified-release prednisone tablet

There are additional products in this therapy area available among Mundipharma’s network of independent associated companies within Asia Pacific, Latin America, the Middle East and Africa that are not currently registered in Singapore. Note that some these products have other names in other jurisdictions.

 

Consumer Health

Please visit http://sg.betadine.com/en/sg/ for information on our Consumer Health portfolio.

↓